Background and Aims Screening, Brief Intervention and Referral to Treatment (SBIRT) is a comprehensive, integrated,
INTRODUCTION
Screening, Brief Intervention and Referral to Treatment (SBIRT) is a comprehensive, integrated, public health approach to the delivery of early intervention and treatment for individuals at risk for the adverse consequences of alcohol and other drug use, and for those with probable substance use disorders. Although several recent US studies have produced equivocal results regarding SBIRT efficacy for illicit drug users [1] , empirical evidence for screening and brief intervention (SBI) for alcohol misuse is well established [2, 3] , and large-scale initiatives have been implemented in countries as diverse as Brazil, Norway, the United Kingdom and Germany [4] . However, translational research, investigating factors associated with successful program implementation (e.g. [5, 6] ), has not kept pace with studies of SBIRT efficacy and effectiveness. The need to address this gap is particularly salient in the United States, as medical facilities attempt to integrate behavioral health into clinical practice to comply with the Affordable Care Act [7] .
SBIRT programs vary considerably in service delivery processes, types of performance sites, provider attributes, patient/client characteristics and management approaches. This diversity provides an opportunity to investigate how program variations are associated with implementation success and, in turn, with treatment outcomes, service costs, systems change and broader societal impacts. The results of such research can also shape the installation of future SBIRT programs by identifying best practices that maximize beneficial treatment outcomes for different populations and service venues.
Currently, there is no widely accepted conceptual framework to guide SBIRT translational research. This paper describes the SBIRT Program Matrix, which was developed to fill this void. A matrix can be defined as a template or mold within which something takes form. The SBIRT Program Matrix provides a template for identifying, classifying and organizing the naturally occurring commonalities and variations within and across SBIRT programs, and for investigating which variables are associated with implementation success and, ultimately, with treatment outcomes and other impacts.
THE SBIRT PROGRAM MATRIX

Overview
Unlike many health-care innovations, SBIRT comprises multiple services, often delivered by different providers across a variety of performance sites. Implementation necessitates partnerships with external organizations (e.g. specialty treatment providers), and there may be multiple, intersecting management structures. Further, SBIRT program components are often interdependent. For example, the choice of service venues determines the types of patients/clients served; similarly, hiring practices affect provider characteristics. To capture this complexity, the SBIRT Program Matrix includes five components, each of which includes multiple elements: SBIRT services, performance sites, provider attributes, patient/client populations and management structure and activities (see Table 1 , Fig. 1 ).
Within this framework, the SBIRT service continuum is the evidence-based innovation that requires translation into real-world settings. In addition to performance sites, provider attributes and patient/client characteristics, which have been investigated in SBIRT research, the Program Matrix includes a management component that is based on evidence regarding the importance of training and supervision protocols, as well as facilitative administrative supports. These 'implementation drivers' are particularly relevant to 'soft' technologies, such as behavioral interventions, that are highly dependent upon service provider skills [5] .
In addition to the SBIRT literature (e.g. [2, 6] ), the development of the Program Matrix was informed by conceptual models in dissemination and implementation science [8] .
There are several such models (e.g. [5, [9] [10] [11] [12] [13] ), which are generic and broadly applicable to different types of innovations and organizations. Our intention was not to supplant these, but rather to apply them in constructing a framework specific to SBIRT. No single model was completely adequate for our purposes. We therefore adapted relevant aspects of a few different frameworks and added specificity regarding the types of variables that reflect the core components of SBIRT programs.
Conceptual frameworks in dissemination and implementation science underscore the importance of distinguishing implementation outcomes (e.g. fidelity, penetration) from patient/client treatment outcomes (e.g. symptom reduction) [12, 13] . This distinction is critical for understanding why programs do not always produce treatment outcomes comparable to those in clinical trials [10] . If SBIRT programs fail to reduce substance use, it is important to determine whether the cause was faulty implementation (e.g. poor provider training resulting in service delivery that does not meet evidence-based standards) or whether the services themselves were ineffective, even when delivered appropriately, in changing substance use behavior in particular real-world settings. Thus, in addition to Program Matrix components, specification of implementation outcomes is needed to evaluate implementation success.
PROGRAM MATRIX COMPONENTS
SBIRT services
The SBIRT continuum of care has evolved to include screening (S), brief intervention (BI) and referral to treatment (RT), which often includes brief treatment (BT) as a Because individuals who use one substance often use others, efficiency is potentially enhanced by screening for multiple substances. The relationship between substance use and mental health problems, and domestic violence, is well established. Although screening efficiency may be improved, intervention and treatment protocols for individuals with multiple risk factors are lacking, and there are questions regarding how best to structure these services (e.g. sequentially versus in parallel) [14] .
Of the risk factors evaluated in SBIRT programs, alcohol misuse has been investigated most often. More than 50 randomized trials of alcohol SBI have been conducted, with efficacy and effectiveness documented in at least 15 systematic reviews and meta-analyses [2, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . The evidence regarding other substances is less consistent. SBI has been shown to reduce cocaine and heroin [28] , cannabis [29] , amphetamine [30] and benzodiazepine [31, 32] use; however, recent clinical trials have been less supportive [33] [34] [35] . Although considerable research supports the efficacy and effectiveness of brief and intensive treatments for alcohol and other substance use, relatively less attention has focused on BT and RT as services within the SBIRT continuum of care.
Each SBIRT service involves a clinical process that can be characterized in terms of assessment instruments, general approaches, specific procedures and administration modalities. In terms of modalities, pre-screening and screening instruments may be self-or staff-administered, a process that can be computer-assisted (an interview conducted by staff using a computerized questionnaire) or computerized (a self-administered questionnaire completed on a computer), or simply involve paper-and-pencil questionnaires. Staff-administration may be performed faceto-face or telephonically. Situations fostering a sense of anonymity (e.g. telephonic or computerized assessment) can enhance self-report veracity regarding alcohol and drug use [36] . Additionally, automated procedures may increase service delivery standardization and improve adherence to evidence-based practice. Direct electronic health record (EHR) data entry and computerized administration have obvious potential for improved efficiency at reduced cost, and telephonic delivery may also facilitate access to care.
Pre-screening
PS tools comprise a small number of questions regarding alcohol and/or drug use; individuals who respond affirmatively are assessed further for patterns of use and related problems with a 'full screening' instrument. SBIRT providers may ask PS questions as an initial stage of the screening process, or items may be embedded within other forms administered at intake by non-SBIRT medical staff.
A large number of single questions and item sets are used to pre-screen for at-risk alcohol use. Widely used, evidence-based tools include the three-item Alcohol Use Disorders Identification Test-C (AUDIT-C) [37, 38] and the National Institute on Alcohol Abuse and Alcoholism question set [39] , which assess the quantity and frequency of alcohol use. Other instruments (sometimes regarded as full screening tools) contain questions about alcohol-related problems or dependence symptoms, including the CAGE (need to Cut-down, others Annoyed, feel Guilty, had an Eye-opener) [40] and the T-ACE (replacing the CAGE guilt question with an item regarding tolerance) [41] .
There are comparatively fewer validated PS instruments for illicit drug use. Examples include some singleitem measures (e.g. [42] ). The first two questions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) serve as a filter for administration of the full questionnaire and are considered an evidenced-based PS option for both alcohol and other drug use [43, 44] . For respondents aged less than 21 years, the CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble) [45] screens for alcohol and for other substance use.
The validity of PS results can be compromised by administration procedures that deviate from evidence-based protocols. Medical personnel, who may be less well trained and/or supervised than dedicated SBIRT staff, often perform PS. Under these conditions, the sensitivity or specificity of validated PS tools may be reduced. When appropriately conducted, however, PS has the potential to increase substantially the number of individuals served and enhance the efficiency of the SBIRT process.
Screening
Screening evaluates the likelihood that an individual has a substance use disorder or is at risk for the adverse consequences of use. Although sometimes conducted by medical staff, dedicated SBIRT service providers also perform screening. Validated instruments are designed to determine a respondent's risk level in order to tailor an intervention to the individual's particular condition; determine the need for further assessment; and/or refer the person to specialty substance abuse treatment and other appropriate services.
Hundreds of tools are available for alcohol screening [46] . Two of the most widely used, the AUDIT [47] and the ASSIST [43, 44] , were developed by the World Health Organization (WHO). Both instruments are supported by large bodies of evidence and have been used in numerous clinical trials, implementation programs and health professional training packages. In addition, many studies have substantiated independently the validity of these instruments across a diversity of medical care settings, countries and patient populations [47] . The AUDIT, a longer version of the AUDIT-C, includes questions regarding alcoholrelated problems, as well as drinking patterns, and is part of a larger package of materials with guidelines for evidence-based BI administration [48] . For those who screen positive, the transition to BI is seamless; responses to screening questions provide the basis for individualized feedback. The ASSIST is designed to screen for at-risk use of illicit drugs and prescription medicines, as well as alcohol; as with the AUDIT, materials include empirically validated BI and self-help manuals [49, 50] .
A variety of modalities are used for screening, including personal interview, self-administered questionnaire and computer-assisted and computerized technologies. Although some research suggests that different modalities influence response veracity [36] , whether these affect screening sensitivity/specificity, service costs or the transition to BI are questions for research.
Brief intervention
BI is a time-limited (5-20 minutes) effort to provide information and/or advice regarding alcohol or other drug use; increase motivation to avoid substance use; and/or teach behavior change skills with the goal of reducing consumption and associated adverse consequences. BI may include follow-up or booster sessions, delivered by telephone or in-person. General medical personnel sometimes deliver BI, but dedicated SBIRT providers also perform this service. Several computerized BI protocols have been developed, and there is mounting evidence to support this modality (e.g. [51] ). As with PS and screening, computerized BI has the potential to increase service efficiency and reduce costs, as well as enhance evidence-based practice and access to care.
BI frequently involves the use of tools for assessing readiness to change. Motivational interviewing (MI) [52, 53] is perhaps the most widely adopted evidenced-based approach; individuals receive personalized feedback regarding the risks associated with use, coupled with advice to facilitate behavior change (e.g. cut back to recommended drinking limits). FRAMES (Feedback, Responsibility, Advice, Menu of options, Empathy and Self-efficacy) [54, 55] is a related, empirically supported approach. The National Institute on Alcohol Use and Alcoholism (NIAAA) [39] or US Department of Agriculture (USDA) drinking guidelines can also be used to structure the advice component of BI. As noted, the WHO AUDIT and ASSIST provide BI manuals.
Brief treatment
Although not part of the SBIRT acronym, BT is identified as a separate service component in many programs, and it is required in federally funded programs in the United States. As an SBIRT service, BT is a RT option for higher-risk program participants. BT involves a limited sequence of structured treatment (usually two to 12 sessions) delivered in an individual (rather than group) format by a licensed behavioral or substance abuse counselor, very often a dedicated SBIRT provider on-site within the SBIRT host medical setting [48] .
BT is a distinct level of care, not an expanded version (e.g. more sessions) of BI. Whereas BI addresses at-risk substance use and provides immediate attention to patients/clients, BT is designed to produce significant behavior change by altering the individual's understanding of factors that influence substance use. When delivered by a licensed behavioral health-care provider BT is a reimbursable, and thereby sustainable, SBIRT service and a key ingredient within an integrated model of primary care [56] . Empirically supported BT approaches are manualdriven and often combine motivational enhancement (MET) [57] and cognitive-behavioral (CBT) [58, 59] therapies. Additionally, the Community Reinforcement Approach (CRA) [60] provides an evidence-based model.
Referral to treatment
RT is provided to individuals who, based on screening results, have a probable substance use disorder diagnosis. Effective RT often includes case management to facilitate treatment initiation and to link the individual with a diagnostic assessment and appropriate service options, including BT, out-patient programs and in-patient facilities. Borrowing from the substance abuse and medical referral literatures, evidence-based RT includes co-location of services, 'warm hand-off ' procedures (i.e. seamless transitions along the continuum of care, preferably involving personal introductions from one provider to another), scheduling appointments prior to medical discharge and provision of transportation or other services (e.g. child care) to enhance access to care. Navigating insurance barriers and the use of free or sliding-scale service providers for low-income patients can also improve treatment access.
Although data are limited regarding SBIRT-specific referral processes, research indicates that BI influences participation in substance abuse treatment [2] . When one hospital replaced referral staff with MI-trained substance abuse counselors, treatment completion rated increased from 40 to 88% [61] . In another study, individuals who received BI more often attended initial interviews at substance abuse treatment facilities than those in the control group (65 versus 5.4%, respectively) [62] . Research has also shown that substance-dependent hospital patients, identified during medical screening, were placed successfully in specialized treatment at rates much greater than controls [61] [62] [63] [64] [65] .
Broad referral networks are essential for the effective expansion of SBI into the SBIRT service continuum. Resources may include in-house facilities (e.g. a detoxification unit or mental health service within the host medical center) and community assistance programs, as well as specialty substance abuse treatment facilities. Network affiliations should provide a range of options appropriate for individuals with differing patterns of substance use and differing needs based on personal circumstances (e.g. insurance coverage, language barriers, limitations imposed by work and family roles, comorbid mental illness). The lack of pre-existing collaborative arrangements between medical and specialty care facilities, and limited numbers of available treatment slots, have been described as implementation barriers in the SBIRT literature [66] . This suggests that the quality and scope of referral networks, as well as communication protocols between general and specialty providers, are important for successful SBIRT program implementation.
Performance sites
As suggested by Table 1 , the performance site characteristic most often discussed in the SBIRT literature is type of medical setting. Most research has been conducted in primary care (most often ambulatory, out-patient) settings where family physicians or medical providers are responsible for SBI [25] . However, emergency departments and trauma centers (ED/TCs) have been described as ideal venues because presenting injuries are often alcohol-or drug-related, offering a 'teachable moment' to those who might not otherwise seek intervention. Additionally, screening is considered most efficient when performed in high-volume locations such as ED/TCs, which also tend to yield relatively high proportions of positive cases. Individuals who frequently use illicit drugs are almost twice as likely to report ED use than those who use less often or not at all [67] , and numerous studies have documented high rates of alcohol and illicit drug use among trauma center patients [68] .
Most setting comparisons in the SBIRT literature have focused on patient treatment outcomes rather than program implementation. Research suggests that, despite the potential advantages of ED/TCs, patients screened in these settings show smaller reductions in alcohol use than those receiving services in other medical settings [4, 25, 26, 69] . The reasons for differences in treatment outcomes are unclear, but it may be more difficult to implement evidencedbased SBIRT programs in ED/TCs than in primary care. ED/TC medical personnel have cited many barriers to SBIRT implementation, including lack of time and the need to attend to severe or life-threatening problems. Patient/client factors may also complicate SBIRT service delivery. Individuals who utilize EDs for routine medical care often have inadequate or no health insurance; those who are substance-involved report mental health problems disproportionately [48] . Thus, populations served by ED/TCs may be more difficult to engage in intervention or treatment and require more services than those screened in other settings, factors that can challenge successful implementation and result potentially in less beneficial treatment outcomes.
A second potentially important performance site distinction is urban versus rural location. Programs located in rural or low-volume venues may not have sufficient patient flow to justify full-time specialist SBIRT staff. Rural clinics, which serve relatively few patients, also tend to screen their entire populations relatively quickly [66] .
An additional performance site characteristic, cited in the dissemination and implementation science literature, is organizational readiness or receptivity [70, 71] . It has been suggested that some host settings are more hospitable to innovation and adopt new evidence-based technologies readily, whereas others are risk-averse and resist change. The differences between the two types of organizations may extend to other factors, such as perceived (or actual) resources, and these may account, at least in part, for observed effects of organizational readiness [72] .
Provider attributes
Because SBI approaches were based initially on preventive services for the early detection of diseases such as cervical cancer and hypertension [73] , the dominant research-topractice SBIRT model relied upon a medical (generalist) provider framework. Typically, a physician, nurse or medical assistant was trained to conduct SBI and monitored by either external or in-house supervisory staff. Despite its common-sense appeal, this model did not produce the expected uptake [74] . As programs evolved, the use of nonmedical substance abuse or behavioral health specialists (e.g. behavioral counselors, substance abuse counselors, social workers, psychologists, health educators) increased [66] . Research suggests that specialist providers can perform as well as generalists in terms of metrics such as screening volume [71] . With the expansion of SBI to include RT and BT, different types of providers often deliver different SBIRT services within the same program. For example, a medical assistant might screen patients during the vital signs process, whereas a dedicated SBIRT specialist might provide BI or BT.
Specific provider type (e.g. nurse, physician) has not been associated consistently with differential SBIRT treatment outcomes [2] ; however, empathy, self-efficacy and the ability to tolerate conditions in medical settings (e.g. exposure to blood, trauma and severe illness) have been cited as important provider characteristics [66] . Nevertheless, relatively few studies have examined directly how provider differences are related specifically to implementation outcomes.
There are reasons to suspect that provider attributes can facilitate or impede SBIRT implementation. For example, several factors cited as barriers to implementation in qualitative studies refer to provider characteristics, including limited SBIRT knowledge, perceived role incompatibility and divergent treatment philosophies [66] . Further, related variables, such as training and supervision (classified here within the management structure and activities component of the Program Matrix) have been associated consistently with quality of service delivery (e.g. fidelity to evidence-based procedures) [5] . In terms of hiring, bachelor's-level providers may be preferable to those with less or more education. Providers at that level have sufficient background to understand program goals and the need for standard service delivery, whereas those with higher levels of education may rely upon previous training more than program protocols. Finally, SBIRT programs often employ providers who are culturally competent or representative of patient/client populations in terms of race/ethnicity.
Based on the limited literature available, Table 1 lists several provider attributes that should be assessed and evaluated in relation to SBIRT implementation (as well as treatment) outcomes: personal characteristics (e.g. gender, race/ethnicity); clinical training (e.g. medical, behavioral health, substance abuse); educational attainment; counseling experience; self-efficacy; and treatment philosophy (public health versus traditional Alcoholics Anonymous).
Patient/client populations
Although they have not been studied extensively in relation to SBIRT, patient/client characteristics might reasonably be expected to affect implementation success and, ultimately, treatment outcomes. As indicated in Table 1 , several classes of attributes are potentially relevant. Risk status refers to the proportion of patients who screen positive and, within this group, the proportions for whom BI, BT and RT are the highest level of recommended SBIRT service. Risk status differences may necessitate differential allocations of program resources. Some demographic characteristics may signal the need for ancillary services (e.g. the recruitment of multi-lingual providers). Indigent patients/clients may encounter obstacles to treatment entry and participation disproportionately; other groups, such as Native Alaskans and Native Americans, or veterans, may be eligible for services in specialized settings. Individuals with family or work obligations may prefer not to enroll in residential or day treatment programs.
Varying patterns of alcohol and other drug use will probably affect the types of services to which patients/clients are referred; similarly, individuals with multiple risk factors, including physical and mental health issues or problematic legal status, may require an array of coordinated services and consume a disproportionate amount of available resources. SBIRT participants screened in health-care settings may have chronic medical conditions that interfere with participation in specialty treatment programs. Prior experiences with substance use treatment in traditional specialty care settings may color patient perspectives regarding treatment options. Thus, the characteristics of specific populations served by SBIRT programs have implications for provider recruitment and training, resource allocation and the types of community and treatment affiliations that will be needed, all of which may potentially influence implementation success.
Management structure and activities
Although they have received relatively little attention in the SBIRT research literature, the elements within the management structure and activities component have been identified as key 'implementation drivers' [5] . The dissemination and implementation science literature indicates that successful installation of innovations requires coordinated change at multiple levels-system, organization, program and practice-and depends, in large measure, on effective program management.
As suggested by Table 1 , the adoption of evidence-based service protocols is the starting-point for effective SBIRT program management. Protocols are detailed, written instructions designed to achieve uniformity in the performance of a specific function or service. Standard Operating Procedures (SOP) manuals should describe SBIRT in terms of background and rationale, goals, service delivery, performance monitoring methods, patient/client flow, emergency procedures and confidentiality measures. Although adaptations to specific settings and circumstances are often needed, protocols should follow as closely as possible the procedures specified in the materials developed for validated PS and screening instruments, BI approaches, treatment technologies and referral processes.
The next three elements listed in Table 1 comprise a cluster of inter-related management elements that bridge the organizational, program and practice levels of analysis. These concern the selection, hiring, training and ongoing management, including coaching and performance evaluation, of SBIRT providers. Staff selection at every organizational level and in all program roles has been proposed as a key driver of successful implementation [5] . As noted, the literature stresses the need for empathetic, culturally competent, SBIRT service delivery personnel, who tolerate well conditions in medical settings [66] .
Training activities should target host-setting personnel, as well as those who deliver SBIRT services. Effective training protocols for SBIRT providers combine didactic education with practice sessions to build skills (e.g. interactive exercises, role-play, standardized patient, activities). Staff coaching and evaluation should be ongoing and include quality assurance (QA) procedures that assess adherence to SBIRT protocols (e.g. shadowing of SBIRT providers, evaluation of taped interactions with patients, recalibration exercises). QA activities should occur routinely at specified time intervals and may involve certification processes.
Program evaluation and dissemination efforts should be both formative and summative, track program performance indicators over time (see below regarding implementation outcomes) and produce data relevant to service providers, supervisors, upper management, key stakeholders, policymakers and prospective SBIRT program sites. Dissemination efforts designed to increase 'buy-in' (e.g. in the host setting) typically involve the efforts of program champions, experts and opinion leaders.
The final element in this component refers to administrative structures and activities that support systems-level interventions that enable and enhance program performance and promote sustained operation over time. Effective administrative supports include leadership at all organizational levels, a factor that has been cited repeatedly as an implementation facilitator [66] . In addition to providing the infrastructure for staff training and supervision, and for ongoing program evaluation and dissemination efforts, SBIRT administrators need to assure that funding is sustainable and that systems-level policies and regulations 'create a hospitable environment for implementation and program operation' ( [5] , p. iv).
IMPLEMENTATION OUTCOMES
Measurable indicators of program performance are needed to evaluate implementation success and to examine systematically which SBIRT program features are best suited for different types of performance sites and patient/client populations. As noted previously, implementation outcomes are distinguished from, but presumed to be associated with, other classes of outcomes that are important for evaluating health-care innovations. Proctor and colleagues distinguish relatively proximal program performance measures, service outcomes (e.g. efficiency, timeliness), from those used to index implementation success [12] . For programs intended to reduce alcohol and other substance use, changes in consumption levels are generally regarded as the most direct (but not the sole) treatment outcome measures for evaluating efficacy and effectiveness [36] . Additionally, health-care innovations such as SBIRT are often envisioned to produce more distal systems-and societal-level impacts (e.g. declines in health-care service utilization and costs, policy changes).
Some studies (e.g. [71] ) have demonstrated that provider and organizational factors are related to SBIRT service delivery metrics (e.g. average screens per month; percentage of those at-risk who receive interventions). Here, we attempt to specify a fuller range of implementation outcomes. Successful program installation implies that SBIRT is feasible and acceptable, both to patients/clients and providers; appropriate to the settings in which it is embedded; well-integrated with other services and systems of care; and delivered with fidelity, ideally in a cost-effective manner. Further, successful implementation implies that programs reach intended target populations, and that they are sustainable over time without major modifications that could compromise evidence-based practice. As a public health initiative, a successful SBIRT program is expected to screen large numbers of individuals representing at-risk populations and to deliver recommended clinical services to those who screen positive for evaluated risk factors. Additionally, grant-funded programs should be evaluated in terms of the extent to which they fulfill funder mandates and achieve project objectives. Collectively, the outcomes described above overlap substantially with constructs included in the 'heuristic, working taxonomy' of implementation outcomes developed by Proctor et al. [12, 13] to 'advance understanding of implementation processes, enhance efficiency in implementation research, and pave the way for studies of the comparative effectiveness of implementation strategies') ( [13] , p. 65). As described by these authors, implementation outcomes can be measured at different levels of analysis (i.e. individual provider, individual consumer, administrator, organization or setting, providing institution), using a wide range of methods (surveys, qualitative or semi-structured interviews, focus groups, observation, administrative data, questionnaires, checklists, case audits). More reliable and valid measurement is achieved by using multiple data sources with different sources of error [36] .
As noted by Proctor et al. [13] , implementation outcomes have been defined conceptually and operationally in somewhat different ways. For example, penetration has been described as program reach or spread and measured by calculating the proportions of eligible individuals served, as well as in terms of institutionalization or routinized performance, which implies program integration within host settings and related systems of care. Proctor and colleagues also note the conceptual overlap between pairs of outcomes (e.g. acceptability and appropriateness; appropriateness and feasibility). Further, because implementation is viewed as an extended process that begins prior to actual program installation, different outcomes are regarded as more or less relevant at particular implementation stages (e.g. appropriateness is most salient prior to adoption, whereas acceptability is relevant across stages). Finally, it is understood that implementation outcomes are likely to be inter-related and that some consequences of implementation probably influence others. For example, penetration, defined as program reach, may promote sustainability. Penetration, as program integration, might affect rates of delivery for recommended clinical services. Table 2 provides a list of candidate implementation outcomes for SBIRT research based on Proctor et al. [12, 13] and informed by public health and other considerations.
The extent to which implementation outcomes are, in fact, inter-related awaits empirical investigation. The development of a comprehensive, core taxonomy of SBIRT implementation outcomes is a necessary condition for examining these inter-relationships and for investigating the extent to which SBIRT Program Matrix components are associated with implementation success. This research, in turn, can provide a blueprint for the transfer of evidencebased SBIRT protocols into varied settings that serve different patient/client populations. Further, it sets the stage for Table 2 Implementation outcomes.
Measure Definition
Adoption Intention, or initial decision, to utilize SBIRT; uptake of services Acceptability Perception that SBIRT is agreeable or palatable to patients, providers, host medical staff, etc.; satisfaction with SBIRT, including content, delivery, comfort level, credibility Appropriateness Perceived fit, relevance, compatibility of SBIRT for a particular setting, type of provider, or patient/client Feasibility The extent to which SBIRT can be carried out within a particular performance site Fidelity
The degree to which SBIRT was implemented as prescribed; adherence to evidence-based protocols Implementation costs Cost impact of SBIRT implementation; marginal costs; cost effectiveness; cost-benefit Penetration Integration of SBIRT within a host medical setting and related systems of care; degree of SBIRT institutionalization, routinization; reach or spread Sustainability Degree to which SBIRT services are maintained within a setting during normal, ongoing operations; continued operation after grant funding ends (if applicable) Service provision to at-risk populations SBIRT service volume: number and proportion of patients/clients screened; rates of delivery of recommended follow-up services Grant compliance if applicable) Achieves SBIRT service targets; rates of follow-up completion; compliance with data monitoring requirements Adapted from Proctor et al. [12, 13] . studies that can examine the potential mediating role that implementation outcomes may play in producing both reductions in substance use and systems-and societal-level impacts.
CONCLUSION
The SBIRT Program Matrix offers a conceptual framework for identifying, classifying and organizing key components within and across SBIRT programs, and for investigating which variables are associated with implementation success and, in turn, with treatment outcomes and societallevel impacts. Research and evaluation findings derived from the application of the SBIRT Program matrix can inform the installation of future SBIRT programs and guide policymaking, as well as contribute to the SBIRT literature and to dissemination and implementation science.
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